We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAN:NYSEManpowerGroup Analysis

Data as of 2026-07-06 - not real-time

$38.44

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ManpowerGroup (MAN) is trading at $38.44, comfortably above its 20‑day SMA of $34.20 and near the identified resistance of $39.45, while the 14‑day RSI of 66 suggests continued buying pressure. Technical momentum is reinforced by a bullish MACD histogram (+0.43) and rising volume, indicating short‑term strength despite a modest downside upside/ downside projection of –6.5%. Fundamentally, the company posts 10% revenue growth and a forward PE of 8.0 versus an industry average of 32.2, positioning it as a relative value play, yet margins are razor‑thin (operating margin ~1%) and cash flow is negative, raising concerns about dividend sustainability (payout ratio 132% with negative earnings). Recent Q3 employment outlook data highlight steady global hiring but a softening trend, with employers increasingly valuing AI literacy—a potential tailwind for MAN’s upskilling services, though larger enterprises are tightening headcount. The stock’s low beta (≈0.37) tempers market risk, but a 30‑day volatility of 58% and a max drawdown of 43% underscore the sector’s cyclical nature. Overall, the price reflects a blend of technical optimism and fundamental caution, making the stock attractive for value‑oriented investors who can tolerate short‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (MACD, RSI, price above 20‑day SMA)
  • Proximity to resistance level limiting upside
  • High dividend payout despite negative earnings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE of 8.0 versus industry PE of 32.2
  • Revenue growth of ~10% and expanding AI‑skill services
  • Attractive dividend yield of 3.7% if earnings improve

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Structural demand for workforce upskilling and flexible staffing
  • Persistent thin margins and negative cash flow
  • Cyclical exposure and high historical volatility

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin-0.09%
P/E Ratio8.0
ROE-0.79%
ROA2.33%
Debt/Equity74.50
P/B Ratio0.9
Op. Cash Flow$-77200000
Free Cash Flow$-46725000
Industry P/E32.2

Technical Analysis

TrendBullish
RSI66.4
Support$31.08
Resistance$39.45
MA 20$34.20
MA 50$31.34
MA 200$31.02
MACDBullish
VolumeIncreasing
Fear & Greed Index93.63

Valuation

Target Price$35.94
Upside/Downside-6.49%
GradeUndervalued
TypeValue
Dividend Yield3.71%

Risk Assessment

Beta0.37
Volatility58.15%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.